營養輔料市場 - 全球產業規模、佔有率、趨勢、機會和預測,2018-2028F 按形式、功能、最終產品、配銷通路、地區、競爭細分
市場調查報告書
商品編碼
1355166

營養輔料市場 - 全球產業規模、佔有率、趨勢、機會和預測,2018-2028F 按形式、功能、最終產品、配銷通路、地區、競爭細分

Nutraceutical Excipients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Form, By Functionality, By End-Product, By Distribution Channel, By Region, Competition

出版日期: | 出版商: TechSci Research | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年全球營養輔料市場價值為 43.2 億美元,預計在預測期內將呈現強勁成長,到 2028 年複合年成長率為 7.2%。營養輔料涵蓋藥物中除活性營養成分外的所有成分。這些分子不具有固有的藥用特性;它們的主要目的是增強藥物的生理吸收。營養保健品賦形劑本質上是惰性的,允許藥物分子以適當的形式給予患者。過去,營養保健品輔料是簡單的分子,但技術的進步和對新型藥物輸送系統不斷成長的需求導致營養保健品輔料的複雜性增加。它們在促進患者接受藥物、提高藥物穩定性和生物利用度方面發揮著至關重要的作用。

輔料科學技術領域發生了重大變化並不斷發展。在賦形劑專著的標準化和應用新的分析方法來更精確地表徵賦形劑等領域取得了顯著進展。

主要市場促進因素

市場概況
預測期 2024-2028
2022 年市場規模 43.2億美元
2028 年市場規模 64.5億美元
2023-2028 年複合年成長率 6.79%
成長最快的細分市場 黏合劑
最大的市場 北美洲

增加營養保健品的應用

營養食品源自於營養和藥物的結合,利用營養食品賦形劑(也稱為「功能性食品」)來增強溶液中活性成分的功效。這些輔料採用活性藥物成分 (API) 製備,廣泛應用於標準化和藥物級補充劑。醫療費用的大幅上漲對營養輔料市場產生了深遠的影響。賦形劑是在生產過程中引入或包含在營養保健品劑型中的惰性物質,在增加固體製劑的體積、確保長期穩定性和促進藥物吸收方面發揮至關重要的作用。此外,它們還增強了產品在使用或儲存過程中的整體安全性和功能特性。由於其用途廣泛,賦形劑已在該領域廣為人知。因此,營養保健品在慢性疾病治療中的使用不斷擴大,推動了全球營養保健品輔料市場對輔料的需求不斷成長。

技術發展

多功能賦形劑屬於包含預處理和共加工變體的賦形劑類別,為製劑提供額外的功能。這些增強的功能包括流動性、可壓縮性、粒徑分佈、形狀和孔隙率等方面。

對營養輔料的需求不斷增加

人們對健康和保健的興趣日益濃厚,加上預防保健意識不斷增強,推動了對營養保健產品的需求。營養保健品輔料在配製這些產品以向消費者提供所需的健康益處方面發揮著至關重要的作用。

營養保健品賦形劑具有多種功能,包括提高產品穩定性、增強生物利用度、掩味、控制釋放曲線以及確保含量均勻性。這種多樣化的功能使它們成為各種營養保健品配方中的重要組成部分。

奈米科技創新

創新輔料技術的引入擴大了營養保健產品開發的可能性。具有增強功能的新型輔料,例如基於奈米技術的輔料,為產品配方和差異化開闢了新途徑。採用奈米技術的藥物傳輸系統(NDDS)來解決藥物毒性的挑戰。營養保健品輔料製造商提供客製化解決方案和輔料混合物,以滿足不同營養保健品配方的特定需求。這種靈活性使配方設計師能夠創造出針對目標市場和消費者偏好進行最佳化的產品。營養保健品產業持續的研究和開發工作導致了新型配方的開發,包括複雜的輸送系統和組合產品。營養保健品賦形劑對於實現這些進步和提高此類製劑的性能至關重要。

主要市場挑戰:

與營養輔料相關的副作用

大多數營養保健品都含有具有多種用途的賦形劑。這些賦形劑在提高產品性能方面發揮著至關重要的作用,例如促進配方、提高患者接受度和依從性,或提供更有效和安全的藥物,如兒童改良釋放配方或掩味糖漿。

值得注意的是,營養保健品賦形劑並不總是像通常認為的那樣是惰性物質。它們可能會導致個人不耐受,或者如果不仔細篩選,會導致藥物發生化學變化,從而產生不良反應。這方面對市場提出了挑戰,並可能影響對此類賦形劑的需求。

研發 (R&D) 投資成本高

輔料和營養保健品經過廣泛的臨床和化學開發,需要大量的研發投資、臨床試驗以及不同國家相關機構的批准。此外,此類產品的開發是一項長期的工作,包括配方、試驗和測試以及商業化。然而,大量的研發投資並不總是能產生相應的生產力回報。即使在成功發現分子之後,將新的營養保健品或賦形劑推向市場的相關成本也相當高。此外,市場上的競爭者可能會開發替代且具有成本效益的解決方案,從而使試驗和測試過程進一步複雜化,並導致在推進產品開發後期階段投入的時間、金錢和精力的浪費。因此,失敗的風險仍然相當大。此外,進行臨床試驗以確定賦形劑有效性的費用相對較高,這對新型賦形劑進入市場構成了重大障礙。

主要市場趨勢

對不同給藥方法和劑型的需求不斷增加

針對慢性疾病的新療法或預防補充劑(例如營養保健品)的開發,以及透過學名藥生產增加獲得藥物的機會以及增加研發支出,在推動替代途徑方面發揮著至關重要的作用。此外,新型藥物傳輸系統(NDDS)以及替代劑量配方和給藥途徑的進步預計將推動對新賦形劑的需求,並帶來市場成長的機會。

對植物性輔料的需求不斷成長

對植物性和純素食產品日益成長的需求也延伸到了營養輔料。製造商正在探索植物性輔料作為源自動物或合成來源的傳統輔料的替代品。

隨著營養保健品產業不斷多元化,對根據特定產品要求量身定做的賦形劑解決方案的需求不斷成長。客製化輔料提供獨特的功能,使製造商能夠在市場上區分其產品。

細分洞見:

對功能的見解:

黏合劑部分根據其功能在營養輔料市場中佔據主導地位,預計將產生重大影響。黏合劑賦形劑在維持製劑結構完整性方面發揮至關重要的作用,特別是在片劑中。透過有效地將成分結合在一起,黏合劑能夠生產具有必要機械強度的片劑、粉末、顆粒和其他產品。

填充劑和稀釋劑在營養輔料市場中也發揮著重要作用。稀釋劑可作為稀釋物質,解決與稠密或黏性液體的流動和泵送性相關的問題。另一方面,填充劑可以增加產品的體積並有助於消費者吸收活性化學物質。透過提高性能和增加體積或重量,填料有助於提高固體材料的成本效益。在補充劑中加入填充劑有助於混合和穩定配方。

最終產品見解:

益生菌預計將成為預測年度成長最快的部分。益生菌由酵母和有益細菌組成,為消費者提供了許多優勢。這些包括改善消化、增強腸道健康、增強免疫力、增加營養吸收、降低食物過敏的風險。益生菌產品有多種形式,如優格、飲料、片劑和膠囊。然而,開發商業上可行的益生菌製劑面臨兩個主要挑戰。首先,確保益生菌賦予的健康屬性的品質。其次,在整個保存期限內保持配方穩定。

本公司積極致力於益生菌混合產品的開發和提供,包括含有多種賦形劑的 API(活性藥物成分)。在這些賦形劑中,甘露醇被認為是最合適的,可以有效提高最終產品的保存期限。值得注意的是,2022年9月13日,雀巢生命花園在中國線下零售市場推出了兩款針對兒童成長和免疫健康的益生菌新品。同樣,2022 年 6 月 1 日,安麗韓國推出了精準益生菌服務,可分析用戶的糞便,為改善腸道微生物群和增加有益短鏈脂肪酸的產量提供量身定做的建議。

預計到 2022 年,北美將保持其在營養輔料市場的主導地位。這可以歸因於杜邦(美國)、凱愛瑞(愛爾蘭)和嘉吉(美國)等主要國際公司在該地區的存在。此外,消費者忙碌的生活方式、忙碌的生活方式導致的慢性病的流行,以及消費者對營養食品(包括食品補充劑)的健康益處的認知不斷提高,都促進了北美營養食品輔料市場的成長。因此,對功能性食品的需求大幅增加。

主要市場參與者

  • ABF成分
  • 嘉吉公司
  • 陶氏公司
  • 杜邦德內穆爾公司
  • EGGLE 瓦瑟堡管理有限公司
  • 希爾瑪成分
  • IMCDGroup Limited
  • 安瑞安公司
  • Innophos 控股公司
  • Jrs Pharma 有限公司

可用的客製化:

全球保健品輔料市場報告以及給定的市場資料,技術科學研究根據公司的具體需求提供客製化服務。該報告可以使用以下自訂選項:

公司資訊

  • 其他市場參與者(最多五個)的詳細分析和概況分析。

目錄

第 1 章:產品概述

第 2 章:研究方法

第 3 章:執行摘要

第 4 章:客戶之聲

第 5 章:全球營養輔料市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按形態(液體、乾燥)
    • 依功能分類(黏合劑、崩解劑、調味劑、包衣劑、填充劑和稀釋劑、潤滑劑、其他功能)
    • 副最終產品(蛋白質和胺基酸、維生素、益生菌、Omega-3 脂肪酸、礦物質、其他最終產品)
    • 按配銷通路(直接招標、零售及其他),
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章:北美營養輔料市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按形式
    • 按功能分類
    • 按最終產品分類
    • 按配銷通路
    • 按國家/地區
  • 北美:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章:歐洲營養輔料市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按形式
    • 按功能分類
    • 按最終產品分類
    • 按配銷通路
    • 按國家/地區
  • 歐洲:國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章:亞太地區營養輔料市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按形式
    • 按功能分類
    • 按最終產品分類
    • 按配銷通路
    • 按國家/地區
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章:南美洲營養輔料市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按形式
    • 按功能分類
    • 按最終產品分類
    • 按配銷通路
    • 按國家/地區
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章:中東和非洲營養輔料市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按形式
    • 按功能分類
    • 按最終產品分類
    • 按配銷通路
    • 按國家/地區
  • MEA:國家分析
    • 南非營養輔料
    • 沙烏地阿拉伯營養輔料
    • 阿拉伯聯合大公國營養輔料

第 11 章:市場動態

第 12 章:市場趨勢與發展

第 13 章:全球營養輔料市場:SWOT 分析

第14章:競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 主要人員
  • SWOT分析
    • ABF Ingredients
    • Cargill, Inc.
    • Dow, Inc.
    • DuPont de Nemours, Inc.
    • EGGLE Wasserburg Verwaltungs GmbH
    • Hilmar Ingredients
    • IMCD Group BV
    • Ingredion, Inc.
    • Innophos Holdings, Inc.
    • Jrs Pharma GmbH Co. KG

第 15 章:策略建議

第 16 章:關於我們與免責聲明

簡介目錄
Product Code: 2432

The global market for nutraceutical excipients was valued at USD 4.32 billion in 2022 and is expected to exhibit robust growth in the forecast period, with a CAGR of 7.2% through 2028. Nutraceutical excipients encompass all components of a drug except for the active nutraceutical ingredients. These molecules do not possess inherent medicinal properties; their primary purpose is to enhance the physiological absorption of the drug. Nutraceutical excipients are inert in nature, allowing the drug molecule to be administered to patients in the appropriate form. In the past, nutraceutical excipients were simple molecules, but advancements in technology and the growing demand for novel drug delivery systems have led to an increase in the complexity of nutraceutical excipients. They play a crucial role in promoting patient acceptance of the drug and improving its stability and bioavailability.

The field of excipient science and technology has undergone significant changes and continues to evolve. Notable progress has been made in areas such as the standardization of excipient monographs and the application of new analytical methods for more precise characterization of excipients.

Key Market Drivers

Market Overview
Forecast Period2024-2028
Market Size 2022USD 4.32 Billion
Market Size 2028USD 6.45 Billion
CAGR 2023-20286.79%
Fastest Growing SegmentBinders
Largest MarketNorth America

Increasing Application of Nutraceuticals

Nutraceuticals, derived from the combination of nutrition and pharmaceuticals, utilize nutraceutical excipients, also known as "functional foods," to enhance the efficacy of active ingredients in solutions. These excipients, prepared with Active Pharmaceutical Ingredients (API), are widely employed in standardized and pharmaceutical-grade supplements. The significant rise in medical costs has had a profound impact on the nutraceutical excipient market. Excipients, which are inert substances introduced during the manufacturing process or included in the dosage form of nutraceutical products, play a crucial role in adding bulk to solid formulations, ensuring long-term stability, and facilitating drug absorption. Moreover, they enhance the overall safety and functional properties of the product during use or storage. Due to their versatile applications, excipients have become well-known in the field. Consequently, the growing demand for excipients in the global nutraceutical excipient market is driven by the expanding utilization of nutraceuticals in the treatment of chronic diseases.

Technological Developments

Multifunctional excipients belong to a category of excipients that encompass pre-processed and co-processed variants, providing additional functionalities to formulations. These enhanced functionalities include aspects such as flowability, compressibility, particle size distribution, shape, and porosity, among others.

The recent surge in demand for specialty excipients, collectively known as multifunctional excipients, can be attributed to the growing interest in stringent manufacturing processes and the emphasis on alternative delivery systems. Nanotechnology-enabled drug delivery systems have gained significant prominence in addressing drug toxicity concerns. Two primary approaches are employed to utilize nanotechnology as a drug delivery system: reducing the size of nutraceutical drug crystals to enhance solubility and bioavailability, and utilizing some form of nano-carrier for effective delivery of active ingredients.

Increasing Demand for Nutraceutical Excipients

The rising interest in health and wellness, coupled with increasing awareness of preventive healthcare, has driven the demand for nutraceutical products. Nutraceutical excipients play a crucial role in formulating these products to deliver desired health benefits to consumers.

Nutraceutical excipients serve various functions, including improving product stability, enhancing bioavailability, providing taste masking, controlling release profiles, and ensuring content uniformity. This diverse range of functions makes them essential components in various nutraceutical formulations.

Innovation in Nanotechnology

The introduction of innovative excipient technologies has expanded the possibilities for nutraceutical product development. Novel excipients with enhanced functionalities, such as nanotechnology-based excipients, have opened new avenues for product formulation and differentiation. Nanotechnology-enabled drug delivery systems (NDDS) are employed to address the challenge of drug toxicity. Nutraceutical excipient manufacturers offer customized solutions and excipient blends tailored to meet the specific needs of different nutraceutical formulations. This flexibility allows formulators to create products optimized for target markets and consumer preferences. Ongoing research and development efforts in the nutraceutical industry have led to the development of novel formulations, including complex delivery systems and combination products. Nutraceutical excipients are crucial in enabling these advancements and improving the performance of such formulations.

Key Market Challenges:

Side Effects Associated with Nutraceutical Excipients

Most nutraceuticals contain excipients that serve various purposes. These excipients play a vital role in enhancing product performance, such as facilitating formulations, improving patient acceptance and compliance, or delivering more effective and safe drugs like modified-release formulations or taste-masked syrups for children.

It is important to note that nutraceutical excipients are not always inert substances as commonly assumed. They can cause intolerance in individuals or, if not carefully screened, lead to chemical changes in the drug, resulting in adverse effects. This aspect poses a challenge to the market and can impact the demand for such excipients.

High Cost of Research and Development (R&D) Investment

Excipients and nutraceutical products undergo extensive clinical and chemical development, necessitating significant R&D investments, clinical trials, and approvals from relevant authorities across different countries/regions. Moreover, the development of such products is a long-term endeavor encompassing formulation, trial and testing, and commercialization. However, substantial R&D investments do not always yield proportional productivity returns. Even after a successful molecule discovery, the costs associated with introducing a new nutraceutical product or excipient to the market are significantly high. Additionally, competing players in the market may develop alternative and cost-effective solutions, further complicating the trial and testing process and leading to wastage of time, money, and effort invested in advancing the later stages of product development. Consequently, the risk of failure remains considerable. Furthermore, the expense of conducting clinical trials to establish the effectiveness of an excipient is relatively high, posing a significant barrier to the market introduction of novel excipients.

Key Market Trends

Increasing Need for Different Delivery Methods and Dosage Forms

The development of new treatments or preventive supplements, such as nutraceuticals, for chronic diseases, along with increased access to medication through generic drug production and heightened research and development spending, plays a crucial role in boosting alternative routes. Furthermore, advancements in novel drug delivery systems (NDDS) and alternative dosage formulations and routes of administration are expected to drive the demand for new excipients and present opportunities for market growth.

Growing Demand for Plant-based Excipients

The increasing demand for plant-based and vegan products has extended to nutraceutical excipients as well. Manufacturers are exploring plant-based excipients as alternatives to traditional excipients derived from animal or synthetic sources.

As the nutraceutical industry continues to diversify, there is a growing need for excipient solutions tailored to specific product requirements. Customized excipients offer unique functionalities and allow manufacturers to differentiate their products in the market.

Segmental Insights:

Insights on Functionality:

The binder segment, depending on its functionality, holds a dominant position in the nutraceutical excipients market and is expected to have a significant impact. Binder excipients play a crucial role in maintaining the structural integrity of formulations, particularly in tablets. By effectively holding the constituents together, binders enable the production of tablets, powders, granules, and other products with the necessary mechanical strength.

Fillers and diluents also play a substantial role in the nutraceutical excipients market. A diluent acts as a substance that dilutes, addressing concerns related to the flow and pumpability of dense or viscous liquids. Fillers, on the other hand, enhance the volume of a product and aid in the absorption of active chemicals by consumers. By improving performance and adding volume or weight, fillers contribute to the cost-effectiveness of solid materials. The inclusion of fillers in supplements helps combine and stabilize the formulation.

End-Product Insights:

Probiotics are expected to be the fastest-growing segment in the forecast year. Probiotics, comprising yeast and beneficial bacteria, offer numerous advantages to consumers. These include improved digestion, enhanced gut health, strengthened immunity, increased nutrient absorption, and reduced risk of food allergies. Probiotic products are available in various forms, such as yogurt, drinks, tablets, and capsules. However, developing a commercially viable probiotic formulation poses two primary challenges. First, ensuring the quality of health attributes conferred by probiotic organisms. Second, maintaining formula stability throughout its shelf life.

Companies are actively engaged in the development and provision of probiotic blend products, including APIs (Active Pharmaceutical Ingredient), incorporating diverse excipients. Among these excipients, mannitol has been identified as the most suitable, effectively enhancing the shelf life of end-products. Notably, on September 13, 2022, Nestle's Garden of Life introduced two new probiotics targeting children's growth and immune health in China's offline retail market. Similarly, on June 1, 2022, Amway Korea launched a precision probiotics service that analyzes users' feces to provide tailored recommendations for improving their gut microbiome and increasing the production of beneficial short-chain fatty acids.

North America is projected to maintain its dominant position in the Nutraceutical Excipients Market in 2022. This can be attributed to the presence of major international companies such as DuPont (US), Kerry (Ireland), and Cargill (US) in the region. Moreover, the busy lifestyles of consumers, the prevalence of chronic diseases resulting from hectic lifestyles, and increasing consumer awareness of the health benefits of nutritional foods, including food supplements, have all contributed to the growth of the Nutraceutical Excipients Market in North America. Consequently, there has been a significant surge in the demand for functional food products.

Key Market Players

  • ABF Ingredients
  • Cargill, Inc.
  • Dow, Inc.
  • DuPont de Nemours, Inc.
  • EGGLE Wasserburg Verwaltungs GmbH
  • Hilmar Ingredients
  • IMCD Group BV
  • Ingredion, Inc.
  • Innophos Holdings, Inc.
  • Jrs Pharma GmbH Co. KG

Report Scope:

In this report, the Global Nutraceutical Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nutraceutical Excipients Market, By Form:

  • Liquid
  • Dry

Nutraceutical Excipients Market, By Functionality:

  • Binders
  • Disintegrants
  • Flavoring Agents
  • Coating Agents
  • Fillers & Diluents
  • Lubricants
  • Other Functionalities

Nutraceutical Excipients Market, By End Product:

  • Protein & Amino Acids
  • Vitamins
  • Probiotics
  • Omega-3 fatty acids
  • Minerals
  • Other End Products

Nutraceutical Excipients Market, By Distribution Channel:

  • Direct Tender
  • Retail Sales
  • Others

Nutraceutical Excipients Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nutraceutical Excipients Market.

Available Customizations:

Global Nutraceutical Excipients Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Nutraceutical Excipients Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Form (Liquid, Dry)
    • 5.2.2. By Functionality (Binders, Disintegrants, Flavoring Agents, Coating Agents, Fillers & Diluents, Lubricants, Other Functionalities)
    • 5.2.3. By End-Product (Protein & Amino Acids, Vitamins, Probiotics, Omega-3 fatty acids, Minerals, Other End Products)
    • 5.2.4. By Distribution Channel (Direct Tender, Retail Sales and Others),
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Market Map

6. North America Nutraceutical Excipients Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Form
    • 6.2.2. By Functionality
    • 6.2.3. By End-Product
    • 6.2.4. By Distribution Channel
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Nutraceutical Excipients Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Form
        • 6.3.1.2.2. By Functionality
        • 6.3.1.2.3. By End-Product
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. Canada Nutraceutical Excipients Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Form
        • 6.3.2.2.2. By Functionality
        • 6.3.2.2.3. By End-Product
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Mexico Nutraceutical Excipients Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Form
        • 6.3.3.2.2. By Functionality
        • 6.3.3.2.3. By End-Product
        • 6.3.3.2.4. By Distribution Channel

7. Europe Nutraceutical Excipients Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Form
    • 7.2.2. By Functionality
    • 7.2.3. By End-Product
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Nutraceutical Excipients Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Form
        • 7.3.1.2.2. By Functionality
        • 7.3.1.2.3. By End-Product
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. United Kingdom Nutraceutical Excipients Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Form
        • 7.3.2.2.2. By Functionality
        • 7.3.2.2.3. By End-Product
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. Italy Nutraceutical Excipients Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Form
        • 7.3.3.2.2. By Functionality
        • 7.3.3.2.3. By End-Product
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. France Nutraceutical Excipients Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Form
        • 7.3.4.2.2. By Functionality
        • 7.3.4.2.3. By End-Product
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. Spain Nutraceutical Excipients Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Form
        • 7.3.5.2.2. By Functionality
        • 7.3.5.2.3. By End-Product
        • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Nutraceutical Excipients Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Form
    • 8.2.2. By Functionality
    • 8.2.3. By End-Product
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Nutraceutical Excipients Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Form
        • 8.3.1.2.2. By Functionality
        • 8.3.1.2.3. By End-Product
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. India Nutraceutical Excipients Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Form
        • 8.3.2.2.2. By Functionality
        • 8.3.2.2.3. By End-Product
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. Japan Nutraceutical Excipients Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Form
        • 8.3.3.2.2. By Functionality
        • 8.3.3.2.3. By End-Product
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. South Korea Nutraceutical Excipients Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Form
        • 8.3.4.2.2. By Functionality
        • 8.3.4.2.3. By End-Product
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Australia Nutraceutical Excipients Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Form
        • 8.3.5.2.2. By Functionality
        • 8.3.5.2.3. By End-Product
        • 8.3.5.2.4. By Distribution Channel

9. South America Nutraceutical Excipients Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Form
    • 9.2.2. By Functionality
    • 9.2.3. By End-Product
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Nutraceutical Excipients Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Form
        • 9.3.1.2.2. By Functionality
        • 9.3.1.2.3. By End-Product
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. Argentina Nutraceutical Excipients Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Form
        • 9.3.2.2.2. By Functionality
        • 9.3.2.2.3. By End-Product
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Colombia Nutraceutical Excipients Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Form
        • 9.3.3.2.2. By Functionality
        • 9.3.3.2.3. By End-Product
        • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Nutraceutical Excipients Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Form
    • 10.2.2. By Functionality
    • 10.2.3. By End-Product
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Nutraceutical Excipients Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Form
        • 10.3.1.2.2. By Functionality
        • 10.3.1.2.3. By End-Product
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Nutraceutical Excipients Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Form
        • 10.3.2.2.2. By Functionality
        • 10.3.2.2.3. By End-Product
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Nutraceutical Excipients Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Form
        • 10.3.3.2.2. By Functionality
        • 10.3.3.2.3. By End-Product
        • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

12. Market Trends & Developments

13. Global Nutraceutical Excipients Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Key Personnel
  • 14.5. SWOT Analysis
    • 14.5.1. ABF Ingredients
    • 14.5.2. Cargill, Inc.
    • 14.5.3. Dow, Inc.
    • 14.5.4. DuPont de Nemours, Inc.
    • 14.5.5. EGGLE Wasserburg Verwaltungs GmbH
    • 14.5.6. Hilmar Ingredients
    • 14.5.7. IMCD Group BV
    • 14.5.8. Ingredion, Inc.
    • 14.5.9. Innophos Holdings, Inc.
    • 14.5.10. Jrs Pharma GmbH Co. KG

15. Strategic Recommendations

16. About Us & Disclaimer